[Some aspects of current medical treatment of bronchopulmonary suppurations]

Due to their frequency, which is still significant in the frame of respiratory pathology, bronchopulmonary suppurations especially those of the secondary type, developing on previously existing lesions such as chronic bronchitis, bronchiectasis, bronchial asthma, bronchial carcinoma, aerial cysts, etc. rise bacteriological, therapeutical and epidemiologic difficulties for the general practitioner. An analysis is presented, of a group of 619 patients with suppurated bronchopneumopathies, hospitalized in 1980 in a department for lung diseases, of whom 116 had primary, and 503 secondary suppurations. In 177 cases (28.5%) monomorphous flora was identified, from the Ps. aeruginosa and Esch. coli strains, as well as Staphylococcus aureus. In 395 patients (64%) cultures remained sterile, and in 171 cases (27.6%) frequent fungal colonies of the Candida genus were evidenced. The medical treatment, which is sometimes difficult due to the severity and the variety of anatomo-clinical forms of the disease, includes, on an individualized basis, symptomatic therapy, anti-infectious and adjuvant therapy dominated by fluidifying drugs, by antibiotics adapted to the various microbial strains, as well as to particular conditions such as acute episodes or superinfections with anaerobic germs. There is an increased interest for re-establishing immunological balance by substitution medication or bio-stimulating preparations such as mono- or polymicrobial vaccines.